Method Of Treating Glaucoma

Abstract

Described are methods for the treatment of ocular hypertension or glaucoma comprising administering a pharmaceutically effective amount of one or more compounds that inhibit the enzyme EgLN-3. Certain embodiments of the invention combine the use of EgLN-3 with other glaucoma treatment agents. The compounds of the invention may be formulated in compositions comprising pharmaceutically acceptable carriers.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 1, 2009
  • Application: Feb 27, 2007
    US US 67962907 A
  • Priority: Feb 27, 2007
    US US 67962907 A
  • Priority: Feb 27, 2006
    US US 77706506 P

Download Citation


Sign in to the Lens

Feedback